Zobrazeno 1 - 10 of 357 pro vyhledávání: '"Leufkens HGM"'
1
Akademický článek
Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities
Autor: Aguiar JP, Heitor Costa L, Alves da Costa F, Leufkens HGM, Martins AP
Publikováno v: Clinical Interventions in Aging, Vol Volume 14, Pp 535-547 (2019)
João Pedro Aguiar,1 Luís Heitor Costa,2 Filipa Alves da Costa,3,4 Hubert GM Leufkens,5 Ana Paula Martins1 1Research Institute for Medicines (iMED.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisboa, Portugal; 2Serviço de Medicina Inte
Externí odkaz: https://doaj.org/article/c4df599aea194df1a04c1b67a3d0f712
Zobrazit plný text záznamu
2
Akademický článek
Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia
Autor: Sagwa EL, Ruswa N, Mavhunga F, Rennie T, Leufkens HGM, Mantel-Teeuwisse AK
Publikováno v: Patient Preference and Adherence, Vol Volume 10, Pp 2369-2377 (2016)
Evans L Sagwa,1 Nunurai Ruswa,2 Farai Mavhunga,2 Timothy Rennie,3 Hubert GM Leufkens,1,4 Aukje K Mantel-Teeuwisse1 1Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht
Externí odkaz: https://doaj.org/article/d6bdaa44f8b6400fb645c899817cc7ab
Zobrazit plný text záznamu
4
Does conditional approval for new oncology drugs in Europe lead to differences in health technology assessment decisions?
Autor: Lipska, I, Hoekman, J, McAuslane, N, Leufkens, Hgm, Hövels, A M, Innovation and Sustainability, Sub Pharmacoepidemiology, Sub Pharmacotherapy, Theoretical, Innovation Studies, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v: Clinical Pharmacology and Therapeutics, 98(5), 489. Nature Publishing Group
An early access pathway of conditional approval for potentially beneficial medicines is available within the European regulatory framework. However, marketing authorization does not necessarily result in recommendations for public funding by health t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd62ee5e92330ca9578db4df28f6b913
https://doi.org/10.1002/cpt.198
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje